Pfizer Says Its Covid Vaccine Is Safe And Generates Robust Immune Response In Kids Ages 5-11
Pfizer has announced that its COVID-19 vaccine is safe and works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters.
For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. The companies tested a two-dose regimen of 10 micrograms — about a third the dosage used for teens and adults — administered three weeks apart and it seen that children developed coronavirus-fighting antibody levels just as strong as teenagers and young adults.
They plan to submit the data to the FDA and other health regulators “as soon as possible.”